Back to THC Overview
NYQ · Valuation Lab
THC
Tenet Healthcare Corporation
Last$261.74
Market cap21.1B
EV/EBITDA7.5x
Intrinsic value
$505.31
MoS +48.2% · Undervalued
Assuming 10.3% FCF margin and 6.8% Y1–5 growth.
Upside to price
EV (DCF)51.8B
Terminal share61%
Expected IV$550.91
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 61% of EV
PV of stage FCFs20.2B
PV of terminal value31.6B
Enterprise value51.8B
Net cash / (debt)-11.1B
Equity value40.7B
Intrinsic value / share$505.31
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 23.3B | 2.4B | 2.2B | 92.6% |
| Y2 | 24.9B | 2.6B | 2.2B | 85.7% |
| Y3 | 26.6B | 2.7B | 2.2B | 79.3% |
| Y4 | 28.4B | 2.9B | 2.1B | 73.4% |
| Y5 | 30.3B | 3.1B | 2.1B | 68.0% |
| Y6 | 31.3B | 3.2B | 2B | 62.9% |
| Y7 | 32.4B | 3.3B | 1.9B | 58.2% |
| Y8 | 33.5B | 3.5B | 1.9B | 53.9% |
| Y9 | 34.6B | 3.6B | 1.8B | 49.9% |
| Y10 | 35.8B | 3.7B | 1.7B | 46.2% |
| Terminal | — | — | 31.6B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.